{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:44:13Z","timestamp":1769021053442,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T00:00:00Z","timestamp":1358640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s12020-013-9881-6","type":"journal-article","created":{"date-parts":[[2013,1,19]],"date-time":"2013-01-19T09:28:11Z","timestamp":1358587691000},"page":"255-263","source":"Crossref","is-referenced-by-count":17,"title":["Involvement of \u03b1-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism"],"prefix":"10.1007","volume":"44","author":[{"given":"Joerg","family":"Latus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meike","family":"Roesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niko","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Steurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Biegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Dippon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Dominik","family":"Alscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,20]]},"reference":[{"issue":"2","key":"9881_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.surg.2004.06.037","volume":"137","author":"ND Perrier","year":"2005","unstructured":"N.D. Perrier, Asymptomatic hyperparathyroidism: a medical misnomer? Surgery 137(2), 127\u2013131 (2005). doi: 10.1016\/j.surg.2004.06.037","journal-title":"Surgery"},{"issue":"7162","key":"9881_CR2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bmj.317.7162.848","volume":"317","author":"E Lundgren","year":"1998","unstructured":"E. Lundgren, E. Szabo, S. Ljunghall, R. Bergstrom, L. Holmberg, J. Rastad, Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism. BMJ 317(7162), 848\u2013851 (1998)","journal-title":"BMJ"},{"issue":"1","key":"9881_CR3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","volume":"41","author":"G Mazziotti","year":"2012","unstructured":"G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58\u201369 (2012). doi: 10.1007\/s12020-011-9570-2","journal-title":"Endocrine"},{"issue":"3","key":"9881_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","volume":"132","author":"JM Ruda","year":"2005","unstructured":"J.M. Ruda, Hollenbeak, CS., Stack BC. Jr.: A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngology\u2013head and neck surgery. Otolaryngol. Head Neck Surg. 132(3), 359\u2013372 (2005). doi: 10.1016\/j.otohns.2004.10.005","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"7","key":"9881_CR5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/bjs.1800820723","volume":"82","author":"D Bartsch","year":"1995","unstructured":"D. Bartsch, C. Nies, C. Hasse, J. Willuhn, M. Rothmund, Clinical and surgical aspects of double adenoma in patients with primary hyperparathyroidism. Br. J. Surg. 82(7), 926\u2013929 (1995)","journal-title":"Br. J. Surg."},{"issue":"3","key":"9881_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12020-011-9452-7","volume":"39","author":"LH Duntas","year":"2011","unstructured":"L.H. Duntas, N. Stathatos, Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects. Endocrine 39(3), 199\u2013204 (2011). doi: 10.1007\/s12020-011-9452-7","journal-title":"Endocrine"},{"issue":"2","key":"9881_CR7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/1097-0347(200102)23:2<134::AID-HED1008>3.0.CO;2-J","volume":"23","author":"B Larian","year":"2001","unstructured":"B. Larian, S. Alavi, J. Roesler, A. Namazie, K. Blackwell, T.C. Calcaterra, M.B. Wang, The role of hyperplasia in multiple parathyroid adenomas. Head Neck 23(2), 134\u2013139 (2001)","journal-title":"Head Neck"},{"issue":"1","key":"9881_CR8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/hupa.2003.55","volume":"34","author":"A Stojadinovic","year":"2003","unstructured":"A. Stojadinovic, A. Hoos, A. Nissan, M.E. Dudas, C. Cordon-Cardo, A.R. Shaha, M.F. Brennan, B. Singh, R.A. Ghossein, Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum. Pathol. 34(1), 54\u201364 (2003). doi: 10.1053\/hupa.2003.55","journal-title":"Hum. Pathol."},{"key":"9881_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7819-6-24","volume":"6","author":"A Gurrado","year":"2008","unstructured":"A. Gurrado, A. Marzullo, G. Lissidini, A. Lippolis, D. Rubini, G. Lastilla, M. Testini, Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level. World J. Surg. Oncol. 6, 24 (2008). doi: 10.1186\/1477-7819-6-24","journal-title":"World J. Surg. Oncol."},{"issue":"12","key":"9881_CR10","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1210\/jc.2004-1597","volume":"89","author":"J Fleischer","year":"2004","unstructured":"J. Fleischer, C. Becker, D. Hamele-Bena, T.L. Breen, S.J. Silverberg, Oxyphil parathyroid adenoma: a malignant presentation of a benign disease. J. Clin. Endocrinol. Metab. 89(12), 5948\u20135951 (2004). doi: 10.1210\/jc.2004-1597","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"9881_CR11","first-page":"215","volume":"27","author":"E Demiralay","year":"2011","unstructured":"E. Demiralay, G. Altaca, B. Demirhan, Morphological evaluation of parathyroid adenomas and immunohistochemical analysis of PCNA and Ki-67 proliferation markers. Turk. Patoloji. Dergisi. 27(3), 215\u2013220 (2011). doi: 10.5146\/tjpath.2011.01078","journal-title":"Turk. Patoloji. Dergisi."},{"key":"9881_CR12","author":"S Varshney","year":"2012","unstructured":"S. Varshney, S.K. Bhadada, U. Nahar, V.N. Shah, A. Bhansali, A. Behera, Chief cell and clear cell parathyroid adenoma do not influence clinical and biochemical expression of the sporadic primary hyperparathyroidism. Endocrine (2012). doi: 10.1007\/s12020-012-9810-0","journal-title":"Endocrine"},{"issue":"3","key":"9881_CR13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2265.2000.01081.x","volume":"53","author":"D Sudhaker Rao","year":"2000","unstructured":"D. Sudhaker Rao, Z.H. Han, E.R. Phillips, S. Palnitkar, A.M. Parfitt, Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clin. Endocrinol. 53(3), 373\u2013381 (2000)","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"9881_CR14","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1210\/jc.85.5.2000","volume":"85","author":"T Carling","year":"2000","unstructured":"T. Carling, J. Rastad, E. Szabo, G. Westin, G. Akerstrom, Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J. Clin. Endocrinol. Metab. 85(5), 2000\u20132003 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"9881_CR15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/eje.0.1480403","volume":"148","author":"S Yano","year":"2003","unstructured":"S. Yano, T. Sugimoto, T. Tsukamoto, K. Chihara, A. Kobayashi, S. Kitazawa, S. Maeda, R. Kitazawa, Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas. Eur. J. Endocrinol. 148(4), 403\u2013411 (2003)","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"9881_CR16","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"I.Z. Ben-Dov, H. Galitzer, V. Lavi-Moshayoff, R. Goetz, M. Kuro-o, M. Mohammadi, R. Sirkis, T. Naveh-Many, J. Silver, The parathyroid is a target organ for FGF23 in rats. J. Clin. Investig. 117(12), 4003\u20134008 (2007). doi: 10.1172\/JCI32409","journal-title":"J. Clin. Investig."},{"issue":"1","key":"9881_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"T. Krajisnik, P. Bjorklund, R. Marsell, O. Ljunggren, G. Akerstrom, K.B. Jonsson, G. Westin, T.E. Larsson, Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J. Endocrinol. 195(1), 125\u2013131 (2007). doi: 10.1677\/JOE-07-0267","journal-title":"J. Endocrinol."},{"issue":"1","key":"9881_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.0.1510055","volume":"151","author":"H Yamashita","year":"2004","unstructured":"H. Yamashita, T. Yamashita, M. Miyamoto, T. Shigematsu, J.J. Kazama, T. Shimada, Y. Yamazaki, S. Fukumoto, M. Fukagaw, S. Noguchi, Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 151(1), 55\u201360 (2004)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"9881_CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/eje.1.02053","volume":"154","author":"K Kobayashi","year":"2006","unstructured":"K. Kobayashi, Y. Imanishi, A. Miyauchi, N. Onoda, T. Kawata, H. Tahara, H. Goto, T. Miki, E. Ishimura, T. Sugimoto, T. Ishikawa, M. Inaba, Y. Nishizawa, Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur. J. Endocrinol. 154(1), 93\u201399 (2006). doi: 10.1530\/eje.1.02053","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"9881_CR20","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1210\/jc.2008-0564","volume":"93","author":"P Bjorklund","year":"2008","unstructured":"P. Bjorklund, T. Krajisnik, G. Akerstrom, G. Westin, T.E. Larsson, Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 93(10), 4152\u20134157 (2008). doi: 10.1210\/jc.2008-0564","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"9881_CR21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nephro.2010.12.011","volume":"7","author":"N Braun","year":"2011","unstructured":"N. Braun, M.D. Alscher, M. Kimmel, K. Amann, M. Buttner, Encapsulating peritoneal sclerosis - an overview. Nephrol. Ther. 7(3), 162\u2013171 (2011). doi: 10.1016\/j.nephro.2010.12.011","journal-title":"Nephrol. Ther."},{"issue":"1","key":"9881_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Wermers","year":"2006","unstructured":"R.A. Wermers, S. Khosla, E.J. Atkinson, S.J. Achenbach, A.L. Oberg, C.S. Grant, L.J. Melton 3rd, Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease. J. Bone. Miner. Res. 21(1), 171\u2013177 (2006). doi: 10.1359\/JBMR.050910","journal-title":"J. Bone. Miner. Res."},{"issue":"3","key":"9881_CR23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","volume":"42","author":"A Garcia-Martin","year":"2012","unstructured":"A. Garcia-Martin, R. Reyes-Garcia, M. Munoz-Torres, Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women. Endocrine 42(3), 764\u2013766 (2012). doi: 10.1007\/s12020-012-9694-z","journal-title":"Endocrine"},{"issue":"2","key":"9881_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1507\/endocrj.K09E-321","volume":"57","author":"K Nakajima","year":"2010","unstructured":"K. Nakajima, T. Okazaki, T. Okamoto, H. Kimura, K. Takano, K. Sato, Genes up- or down-regulated by high calcium medium in parathyroid tissue explants from patients with primary hyperparathyroidism. Endocr. J. 57(2), 153\u2013159 (2010)","journal-title":"Endocr. J."},{"issue":"7120","key":"9881_CR25","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"I. Urakawa, Y. Yamazaki, T. Shimada, K. Iijima, H. Hasegawa, K. Okawa, T. Fujita, S. Fukumoto, T. Yamashita, Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444(7120), 770\u2013774 (2006). doi: 10.1038\/nature05315","journal-title":"Nature"},{"issue":"10","key":"9881_CR26","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","volume":"18","author":"T Kawata","year":"2007","unstructured":"T. Kawata, Y. Imanishi, K. Kobayashi, T. Miki, A. Arnold, M. Inaba, Y. Nishizawa, Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J. Am. Soc. Nephrol. 18(10), 2683\u20132688 (2007). doi: 10.1681\/ASN.2006070783","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5831","key":"9881_CR27","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1126\/science.1135901","volume":"316","author":"A Imura","year":"2007","unstructured":"A. Imura, Y. Tsuji, M. Murata, R. Maeda, K. Kubota, A. Iwano, C. Obuse, K. Togashi, M. Tominaga, N. Kita, K. Tomiyama, J. Iijima, Y. Nabeshima, M. Fujioka, R. Asato, S. Tanaka, K. Kojima, J. Ito, K. Nozaki, N. Hashimoto, T. Ito, T. Nishio, T. Uchiyama, T. Fujimori, Y. Nabeshima, Alpha-klotho as a regulator of calcium homeostasis. Science 316(5831), 1615\u20131618 (2007). doi: 10.1126\/science.1135901","journal-title":"Science"},{"issue":"3","key":"9881_CR28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000274483","volume":"31","author":"C Kumata","year":"2010","unstructured":"C. Kumata, M. Mizobuchi, H. Ogata, F. Koiwa, A. Nakazawa, F. Kondo, Y. Kadokura, E. Kinugasa, T. Akizawa, Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism. Am. J. Nephrol. 31(3), 230\u2013238 (2010). doi: 10.1159\/000274483","journal-title":"Am. J. Nephrol."},{"issue":"3","key":"9881_CR29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","volume":"77","author":"H Komaba","year":"2010","unstructured":"H. Komaba, S. Goto, H. Fujii, Y. Hamada, A. Kobayashi, K. Shibuya, Y. Tominaga, N. Otsuki, K. Nibu, K. Nakagawa, N. Tsugawa, T. Okano, R. Kitazawa, M. Fukagawa, T. Kita, Depressed expression of klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int. 77(3), 232\u2013238 (2010). doi: 10.1038\/ki.2009.414","journal-title":"Kidney Int."},{"issue":"10","key":"9881_CR30","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1210\/jc.82.10.3481","volume":"82","author":"F Farnebo","year":"1997","unstructured":"F. Farnebo, U. Enberg, L. Grimelius, M. Backdahl, M. Schalling, C. Larsson, L.O. Farnebo, Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 82(10), 3481\u20133486 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"9881_CR31","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jc.81.4.1598","volume":"81","author":"O Kifor","year":"1996","unstructured":"O. Kifor, F.D. Moore Jr, P. Wang, M. Goldstein, P. Vassilev, I. Kifor, S.C. Hebert, E.M. Brown, Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J. Clin. Endocrinol. Metab. 81(4), 1598\u20131606 (1996)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-9881-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-013-9881-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-9881-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:47Z","timestamp":1559440607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-013-9881-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9881"],"URL":"https:\/\/doi.org\/10.1007\/s12020-013-9881-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,20]]}}}